Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL516558 | 0.84 | HTT (0.57) | HTTLMNAMAPTALDH1A1HPGD | |
| SCHEMBL27749003 | 0.74 | HTT (0.47) | HTTLMNAMAPTALDH1A1HPGD | |
| SCHEMBL5117540 | 0.68 | HTT (0.54) | HTTLMNAMAPTALDH1A1HPGD | |
| SCHEMBL3458498 | 0.68 | HTT (0.57) | HTTLMNAMAPTALDH1A1HPGD | |
| SCHEMBL30665799 | 0.68 | HTT (0.57) | HTTLMNAMAPTALDH1A1HPGD | |
| SCHEMBL3521038 | 0.68 | HTT (0.58) | HTTLMNAMAPTALDH1A1HPGD | |
| SCHEMBL11127797 | 0.67 | HTT (0.53) | HTTLMNAMAPTALDH1A1HPGD | |
| Pyrazine SCHEMBL1198105 | 0.67 | L3MBTL1 (0.33) | HTTLMNAMAPTALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL28203639 | 0.66 | HTT (0.56) | HTTLMNAMAPTALDH1A1HPGD | |
| SCHEMBL27914649 | 0.66 | HTT (0.56) | HTTLMNAMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090191394-A1 | Oarganic Compound, Optical Crystal Film and Method of Production Thereof | CRYSOPTIX K.K. (JP) | 2009-07-30 | — | — | US | claimed |
| EP-1931644-A2 | ACENAPHTHOQUINOXALINE SULFONAMIDE DERIVATIVES, OPTICAL CRYSTAL FILM AND METHOD OF PRODUCTION THEREOF | Crysoptix Limited (CY) | 2008-06-18 | — | — | EP | claimed |
| WO-2007042788-A2 | ACENAPHTHOQUINOXALINE SULFONAMIDE DERIVATIVES, OPTICAL CRYSTAL FILM AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX LIMITED (CY) | 2007-04-19 | — | — | WO | claimed |
| US-RE47117-E1 | Compensated in-plane switching mode liquid crystal display | CRYSOPTIX K.K. (JP) | 2018-11-06 | — | — | US | disclosed |
| EP-2010949-B1 | BACKLIGHT MODULE AND LIQUID CRYSTAL DISPLAY INCORPORATING THE SAME | CRYSOPTIX KK (JP) | 2014-09-10 | — | — | EP | disclosed |
| US-8416376-B2 | Compensated in-plane switching mode liquid crystal display | CRYSOPTIX KK (JP) | 2013-04-09 | — | — | US | disclosed |
| US-7889297-B2 | Liquid crystal display operating in a vertically aligned mode | Crysoptix, KK (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100149471-A1 | Compensated In-Plane Switching Mode Liquid Crystal Display | CRYSOPTIX KK (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100118241-A1 | Liquid Crystal Display Operating in a Vertically Aligned Mode | CRYSOPTIX KK (JP) | 2010-05-13 | — | — | US | disclosed |
| US-20090191394-A1 | Oarganic Compound, Optical Crystal Film and Method of Production Thereof | CRYSOPTIX K.K. (JP) | 2009-07-30 | — | — | US | disclosed |
| US-20090191394-A1 | Oarganic Compound, Optical Crystal Film and Method of Production Thereof | CRYSOPTIX K.K. (JP) | 2009-07-30 | — | — | US | disclosed |
| CN-101282947-A | Acenaphthoquinoxaline sulfonamide derivative, optical crystal film and preparation method thereof | CRYSOPTIX LTD (JP) | 2008-10-08 | — | — | CN | disclosed |
| EP-1931644-A2 | ACENAPHTHOQUINOXALINE SULFONAMIDE DERIVATIVES, OPTICAL CRYSTAL FILM AND METHOD OF PRODUCTION THEREOF | Crysoptix Limited (CY) | 2008-06-18 | — | — | EP | disclosed |
| EP-1931644-A2 | ACENAPHTHOQUINOXALINE SULFONAMIDE DERIVATIVES, OPTICAL CRYSTAL FILM AND METHOD OF PRODUCTION THEREOF | Crysoptix Limited (CY) | 2008-06-18 | — | — | EP | disclosed |
| WO-2007141025-A2 | LIQUID CRYSTAL DISPLAY OPERATING IN A VERTICALLY ALIGNED MODE | CRYSOPTIX K.K. (JP) | 2007-12-13 | — | — | WO | disclosed |
| WO-2007122389-A2 | BACKLIGHT MODULE AND LIQUID CRYSTAL DISPLAY INCORPORATING THE SAME | CRYSOPTIX K.K. (JP) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007042788-A3 | ACENAPHTHOQUINOXALINE SULFONAMIDE DERIVATIVES, OPTICAL CRYSTAL FILM AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX LTD (CY) | 2007-09-07 | — | — | WO | disclosed |
| WO-2007083158-A2 | MULTILAYER POLARIZER | CRYSOPTIX K.K. (JP) | 2007-07-26 | — | — | WO | disclosed |
| WO-2007042788-A2 | ACENAPHTHOQUINOXALINE SULFONAMIDE DERIVATIVES, OPTICAL CRYSTAL FILM AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX LIMITED (CY) | 2007-04-19 | — | — | WO | disclosed |
| WO-2007042788-A2 | ACENAPHTHOQUINOXALINE SULFONAMIDE DERIVATIVES, OPTICAL CRYSTAL FILM AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX LIMITED (CY) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090191394-A1 | Oarganic Compound, Optical Crystal Film and Method of Production Thereof | HCN3, CFH, KCNH1 | HTT 2568/4885LMNA 895/4885MAPT 2196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.